Recombinant Human Noggin Protein

Product Code: GFC0579

Catalog Number Unit Size Price
GFC0579-25 ug 25 ug Online Inquiry
GFC0579-100 ug 100 ug Online Inquiry
GFC0579-1 mg 1 mg Online Inquiry

Description

Noggin, also known as NOG, SYM1, and SYNS1, is a secreted homodimeric glycoprotein. Noggin inhibits TGF-β signal transduction by binding to TGF-β family ligands and preventing them from binding to their corresponding receptors. Noggin was originally identified as a BMP-4 antagonist whose action is critical for proper formation of the head and other dorsal structures.
Noggin is essential for proper skeletal development, excess BMP activity in the Noggin null mutant results in excess cartilage and failure to initiate joint formation.
During the culture of human embryonic stem cells (hESC) or neural stem cells under certain conditions, addition of Noggin to antagonize BMP activity may allow stem cells to proliferate while maintaining their undifferentiated state, or alternatively, to differentiate into dopaminergic neurons. Noggin also appears to maintain adult stem cell populations in vivo, for example, maintaining neural stem cells within the hippocampus.

Specification

Source
Mouse myeloma cell line, NS0-derived human Noggin protein, Gln28-Cys232
Reactivity
Human
N-terminal Sequence
No results obtained: Gln28 predicted
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
Molecular Mass (Predicted)
23 kDa (monomer)
SDS-PAGE
30-33 kDa, reducing conditions
Accession
Q13253
Biological Activity
Measured by its ability to inhibit BMP-4-induced alkaline phosphatase production by ATDC5 mouse chondrogenic cells. The ED50 for this effect is 0.0200-0.160 μg/mL in the presence of 50 ng/mL of Recombinant Human BMP‑4 (Catalog # 314-BP).
Endotoxin
<0.10 EU per 1 μg of the protein by the LAL method.
Application
Bioactivity
For research or further manufacturing use only. Not for use in humans.

CONTACT US

USA
Europe

ABOUT US

As a pioneer of biotechnology, Creative Bioarray has developed into a leading biotechnology company in the world. We are committed to providing our customers with innovative high-quality products and services through discovering, developing, and manufacturing.

Copyright © 2024 Creative Bioarray. All rights reserved.